TrialBreast cancer research : BCR2014

Relationship of PIK3CA mutation and pathway activity with antiproliferative response to aromatase inhibition.

Elena López-Knowles et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.